Lee Guan LimTakao ItoiWee Chian LimSteven Joseph MesenasDong Wan SeoJonard TanHsiu Po WangThawatchai AkaraviputhSandeep LakhtakiaSalem OmarThawee RantachuSharmila SachitanandanKenjiro YasudaShyam VaradarajuluJennie WongVinay DhirKhek Yu HoNational University Health SystemNational University of SingaporeYong Loo Lin School of MedicineTokyo Medical UniversityKyoto Daini Sekijyuji ByoinUniversity of Ulsan, College of MedicineSt Luke's Medical Center-Bonifacio Global CityNational Taiwan University HospitalMahidol UniversityRajavithi HospitalAsian Institute of Gastroenterology IndiaUniversity of MalayaSime Darby HealthcareUniversity of AlabamaInstitute of Advanced EndoscopyS.L. Raheja Hospital (A Fortis Associate)2018-05-032018-05-032011-01-01Journal of Gastroenterology and Hepatology (Australia). Vol.26, No.12 (2011), 1702-170814401746081593192-s2.0-81855206327https://repository.li.mahidol.ac.th/handle/20.500.14594/12782Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (EUS-FNA) play increasingly prominent roles in the diagnosis and management of pancreatic cysts. The Asian Consortium of Endoscopic Ultrasound was recently formed to conduct collaborative research in this area. This is a review of literature on true pancreatic cysts. Due to the lack of systematic studies, there are no robust data on the true incidence of pancreatic cystic lesions in Asia and any change in over the recent decades. Certain EUS morphological features have been used to predict particular types of pancreatic cysts. Pancreatic cyst fluid viscosity, cytology, pancreatic enzymes, and tumor markers, in particular carcinoembryonic antigen, can aid in the diagnosis of pancreatic cysts. Hemorrhage and infection are the most common complications of EUS-FNA of pancreatic cysts. Pancreatic cysts can either be observed or resected depending on the benign or malignant nature, or malignant potential of the lesions. Guidelines from an international consensus did not require positive cytological findings to be present in their recommendation for resection, which included all mucinous cystic neoplasms, all main-duct intraductal papillary mucinous neoplasms (IPMN), all mixed IPMN, symptomatic side-branch IPMN, and side-branch IPMN larger than 3cm. In patients with poor surgical risks, EUS-guided cyst ablation of mucinous pancreatic cysts is an alternative. As long-term prospective data on pancreatic cysts are still not available in Asia, management strategies are largely based on risk stratification by surgical risk and malignant potential. Gene expression profiling of pancreatic cyst fluid and confocal laser endomicroscopic examination of pancreatic cysts are novel techniques currently being studied. © 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.Mahidol UniversityMedicineReviewSCOPUS10.1111/j.1440-1746.2011.06884.x